A Self-Homing and Traceable Cardiac Patch Leveraging Ferumoxytol for Spatiotemporal Therapeutic Delivery
- 16 January 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (4) , 3073-3086
Abstract
Mesenchymal stem cell (MSC)-based cardiac patches are envisioned to be a promising treatment option for patients with myocardial infarction. However, their therapeutic efficacy and duration are hampered due to their limited retention on the epicardium. We engineered a scaffold-free MSC sheet with an inherent ability to migrate into the infarcted myocardium, a strategy enabled by actively establishing a sustained intracellular hypoxic environment through the endocytosis of our FDA-approved ferumoxytol. This iron oxide nanoparticle stabilized hypoxia-induced factor-1α, triggering upregulation of the CXC chemokine receptor and subsequent MSC chemotaxis. Thus, MSCs integrated into 2/3 depth of the left ventricular anterior wall in a rat model of acute myocardial infarction and persisted for at least 28 days. This led to spatiotemporal delivery of paracrine factors by MSCs, enhancing cardiac regeneration and function. Ferumoxytol also facilitated the noninvasive MRI tracking of implanted MSCs. Our approach introduces a strategy for mobilizing MSC migration, holding promise for rapid clinical translation in myocardial infarction treatment.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20222002)
- National Natural Science Foundation of China (51832001)
This publication has 72 references indexed in Scilit:
- Fabrication of functional three-dimensional tissues by stacking cell sheets in vitroNature Protocols, 2012
- Immunomodulatory properties and therapeutic application of mesenchymal stem cellsClinical and Experimental Immunology, 2011
- Xenografted Human Amniotic Membrane–Derived Mesenchymal Stem Cells Are Immunologically Tolerated and Transdifferentiated Into CardiomyocytesCirculation Research, 2010
- Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxiaBlood, 2009
- Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodelAnnals of Medicine, 2006
- Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissueBiotechnology and Bioengineering, 2005
- Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic isletsBlood, 2005
- Gender differences in cardiac function during early remodeling after acute myocardial infarction in miceLife Sciences, 2004
- Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following cultureLeukemia, 2003
- A novel recovery system for cultured cells using plasma‐treated polystyrene dishes grafted with poly(N‐isopropylacrylamide)Journal of Biomedical Materials Research, 1993